15-Year watch begins for CAR t cell therapy recipients
NCT ID NCT04911478
First seen Apr 18, 2026 · Last updated Jun 15, 2026 · Updated 13 times
Summary
This study tracks 50 people who previously received an experimental CAR T cell therapy for certain lymphomas. The goal is to watch for long-term side effects and check how well patients do over 15 years. No new treatment is given, but patients can receive other cancer therapies during follow-up.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor Scott & White Research Institute
Dallas, Texas, 75204, United States
-
Blood and Marrow Transplant Program
Palo Alto, California, 94304, United States
-
MD Anderson Caner Center
Houston, Texas, 77030, United States
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Norton Cancer Institute
Louisville, Kentucky, 40207, United States
Conditions
Explore the condition pages connected to this study.